Segmentectomy for Lung Adenocarcinoma: The Impact of EGFR Mutation Status on Recurrence

被引：0
|
作者：
Hyun, K. [1 ]
Park, S. [1 ]
Lee, H. J. [1 ]
Park, I. K. [2 ]
Kim, Y. [2 ]
Kang, C. H. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Thorac & Cardiovasc Surg, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
segmentectomy; EGFR; Adenocarcinoma;
D O I：
10.1016/j.jtho.2017.09.1828
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.16-022
引用
收藏
页码：S2351 / S2351
页数：1
相关论文
共 50 条
  • [31] EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
    Smits, Alexander J. J.
    Kummer, J. Alain
    Hinrichs, John W. J.
    Herder, Gerarda J. M.
    Scheidel-Jacobse, Karen C.
    Jiwa, N. Mehdi
    Ruijter, T. Emiel G.
    Nooijen, Peet T. G. A.
    Looijen-Salamon, Monica G.
    Ligtenberg, Marjolijn J. L.
    Thunnissen, Frederik B.
    Heideman, Danielle A. M.
    de Weger, Roel A.
    Vink, Aryan
    CELLULAR ONCOLOGY, 2012, 35 (03) : 189 - 196
  • [32] Is it Unjustified to Perform Segmentectomy in Surgical Treatment of Lung Adenocarcinoma?
    Sezer, Huseyin Fatih
    Elicora, Aykut
    Topcu, Salih
    ARCHIVES OF IRANIAN MEDICINE, 2021, 24 (06) : 487 - 495
  • [33] Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma
    Hasanovic, Adnan
    Ang, Daphne
    Moreira, Andre L.
    Zakowski, Maureen F.
    LUNG CANCER, 2012, 77 (02) : 299 - 305
  • [34] EGFR Mutation Status as a Prognostic Marker in Stage 1 Lung Adenocarcinoma After Definitive Surgical Resection
    Galvez, C.
    Jacob, S.
    Zhao, J.
    Tegtmeyer, K.
    Finkelman, B.
    Chae, Y. K.
    Mohindra, N.
    Jovanovic, B.
    Behdad, A.
    Villaflor, V.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S433 - S433
  • [35] EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma
    Toki, Maria I.
    Carvajal-Hausdorf, Daniel E.
    Altan, Mehmet
    McLaughlin, Joseph
    Henick, Brian
    Schalper, Kurt A.
    Syrigos, Konstantinos N.
    Rimm, David L.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 1901 - 1911
  • [36] Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
    Girard, N.
    Sima, C. S.
    Jackman, D. M.
    Sequist, L. V.
    Chen, H.
    Yang, J. C-H.
    Ji, H.
    Waltman, B.
    Rosell, R.
    Taron, M.
    Zakowski, M. F.
    Ladanyi, M.
    Riely, G.
    Pao, W.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (02) : 366 - 372
  • [37] TO EVALUATE THE CORRELATION OF EGFR MUTATION BETWEEN TISSUE BIOPSY AND CIRCULATING LUNG CANCER CELLS IN ADENOCARCINOMA LUNG
    Jan, R.
    Bashir, M.
    Husain, M.
    Bagdadi, F.
    Saleh, T.
    CHEST, 2022, 161 (06) : 320A - 320A
  • [38] KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma
    Xu, Hui
    Shao, Chuan
    ONCOTARGETS AND THERAPY, 2020, 13 : 8317 - 8321
  • [39] Relation of EGFR Mutation Status to Metabolic Activity in Localized Lung Adenocarcinoma and Its Influence on the Use of FDG PET/CT Parameters in Prognosis
    Kim, Yong-il
    Paeng, Jin Chul
    Park, Young Sik
    Cheon, Gi Jeong
    Lee, Dong Soo
    Chung, June-Key
    Kang, Keon Wook
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 210 (06) : 1346 - 1351
  • [40] EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system
    Nomura, Kotaro
    Aokage, Keiju
    Kaminuma, Yasunori
    Nakai, Tokiko
    Wakabayashi, Masashi
    Ikeno, Takashi
    Koike, Yutaro
    Taki, Tetsuro
    Miyoshi, Tomohiro
    Tane, Kenta
    Samejima, Joji
    Ishii, Genichiro
    Tsuboi, Masahiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (03) : 297 - 308
12345